Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Non-cash Items (2019 - 2024)

Fortress Biotech has reported Non-cash Items over the past 5 years, most recently at $400000.0 for Q4 2024.

  • Quarterly results put Non-cash Items at $400000.0 for Q4 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $400000.0 (changed N/A YoY), and the annual figure for FY2024 was $400000.0, changed.
  • Non-cash Items for Q4 2024 was $400000.0 at Fortress Biotech, down from $600000.0 in the prior quarter.
  • Over the last five years, Non-cash Items for FBIO hit a ceiling of $400.0 million in Q1 2024 and a floor of $100000.0 in Q4 2022.
  • Median Non-cash Items over the past 4 years was $600000.0 (2023), compared with a mean of $39.7 million.
  • Peak annual rise in Non-cash Items hit 66566.67% in 2024, while the deepest fall reached 0.0% in 2024.
  • Fortress Biotech's Non-cash Items stood at $17.5 million in 2020, then tumbled by 99.43% to $100000.0 in 2022, then soared by 300.0% to $400000.0 in 2023, then changed by 0.0% to $400000.0 in 2024.
  • The last three reported values for Non-cash Items were $400000.0 (Q4 2024), $600000.0 (Q3 2024), and $600000.0 (Q2 2024) per Business Quant data.